1. Home
  2. SRI vs SPRO Comparison

SRI vs SPRO Comparison

Compare SRI & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$5.58

Market Cap

161.7M

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.66

Market Cap

135.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
SPRO
Founded
1965
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
135.5M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
SRI
SPRO
Price
$5.58
$2.66
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
300.3K
332.3K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
111.81
EPS
N/A
0.15
Revenue
$824,444,000.00
$66,802,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.73
$300.00
P/E Ratio
N/A
$18.53
Revenue Growth
18.46
39.24
52 Week Low
$3.59
$0.58
52 Week High
$9.71
$3.09

Technical Indicators

Market Signals
Indicator
SRI
SPRO
Relative Strength Index (RSI) 46.96 60.90
Support Level $4.60 $2.15
Resistance Level $5.72 $2.70
Average True Range (ATR) 0.30 0.14
MACD 0.12 0.03
Stochastic Oscillator 87.50 76.27

Price Performance

Historical Comparison
SRI
SPRO

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: